References
- Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. doi:https://doi.org/10.1056/NEJMoa2015432.
- Singhania N, Bansal S, Nimmatoori DP, Ejaz AA, McCullough PA, Singhania G. Current overview on hypercoagulability in COVID-19. Am J Cardiovasc Drugs. 2020;20(5):393–403. doi:https://doi.org/10.1007/s40256-020-00431-z.
- Ghasemian R, Shamshirian A, Heydari K, Malekan M, Alizadeh-Navaei R, Ebrahimzadeh MA, Ebrahimi Warkiani M, Jafarpour H, Razavi Bazaz S, Rezaei Shahmirzadi A, et al. The role of vitamin D in the age of COVID-19: a systematic review and meta-analysis. Int J Clin Pract. 2021;75(11):e14675. doi:https://doi.org/10.1111/ijcp.14675.
- Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–6. doi:https://doi.org/10.2310/JIM.0b013e31821b8755.
- Ganji V, Al-Obahi A, Yusuf S, Dookhy Z, Shi Z. Serum vitamin D is associated with improved lung function markers but not with prevalence of asthma, emphysema, and chronic bronchitis. Sci Rep. 2020;10(1):11542. doi:https://doi.org/10.1038/s41598-020-67967-7.
- Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf M-I, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, et al. Vitamin D supplementation for the treatment of COVID‐19: a living systematic review. Cochrane Database Syst Rev. 2021;5(5):CD015043. doi:https://doi.org/10.1002/14651858.CD015043.